Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JAM van Laar is a professional medical consultancy and clinical research entity centered around the expertise of Dr. Jan A.M. van Laar, a leading Dutch clinical immunologist and rheumatologist. The entity is primarily involved in the design, leadership, and execution of clinical trials for complex autoimmune and autoinflammatory diseases, with a particular focus on systemic sclerosis and Behçet's disease. Dr. van Laar is internationally recognized for his role as a principal investigator in international multicenter trials, including the landmark ASTIS trial investigating autologous stem cell transplantation. Based in Rotterdam, the entity provides specialized consulting services to pharmaceutical companies, academic institutions, and healthcare providers in the fields of immunology and rheumatology. Its work bridges the gap between academic research and clinical application, contributing to the development of novel therapeutic strategies for rare inflammatory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JAM van Laar.